FDA Approves Treatment for Moderate-to-Severe Chronic Hand Eczema
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
Regulatory approval is based on clinical trials showing improvements in symptom severity and treatment success at 16 weeks.
The professional-exclusive serum and cream use epidermal growth factor and amino acids to support skin barrier repair, with small clinical studies reporting improvements in redness, hydration, and recovery following aesthetic procedures.